Krish W. Ramadurai

Krish W. Ramadurai is a Partner at AIX Ventures, focusing on investments at the intersection of Healthcare, Life Sciences, and Artificial Intelligence. Ramadurai serves as a Venture Mentor for the National Venture Capital Association and as a Venture Advisor for Nucleate, an organization aimed at empowering emerging biotech leaders. In addition, Ramadurai is a Guest Lecturer at Harvard University, with expertise in Tissue Engineering and Biochemical Engineering. Previous roles include Board Chairman and Investor at PreciPoint, Board Observer and Investor at xCures and Sorcero, and Investor at companies such as bit.bio, Attivare Therapeutics, and Caresyntax. Ramadurai holds a DPhil in Engineering Science, an MSc in Nanotechnology for Medicine, an MBA, and a Master's in Biology from esteemed institutions including the University of Oxford, Washington University in St. Louis, and Harvard University, as well as a Bachelor's degree from the University of Illinois Urbana-Champaign.